Results 121 to 130 of about 20,308 (302)

Heart failure in two male patients with late‐onset Fabry mutation (IVS4 + 919G > A)

ESC Heart Failure, Volume 12, Issue 2, Page 1508-1513, April 2025.
Xufei Yang, Chunlan Deng, Xiaogang Guo, Hui Yan   +3 more
wiley   +1 more source

Cognition–Eye–Brain Connection in Alzheimer's Disease Spectrum Revealed by Multimodal Imaging

Journal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Background The connection between cognition, eye, and brain remains inconclusive in Alzheimer's disease (AD) spectrum disorders. Purpose To explore the relationship between cognitive function, retinal biometrics, and brain alterations in the AD spectrum. Study Type Prospective.
Yan Shi, Tingting Shen, Su Yan, Jianwen Liang, Tianyunxi Wei, Yijin Huang, Rong Gao, Ning Zheng, Renpuchi Ci, Min Zhang, Xiaoying Tang, Yuanyuan Qin, Wenzhen Zhu   +12 more
wiley   +1 more source

Utilization of Ciprofloxacin‐Dexamethasone in the Airway: A Scoping Review

The Laryngoscope, EarlyView.
Off‐label ciprofloxacin‐dexamethasone has been used for over two decades to improve outcomes following airway surgery. Therefore, this scoping review evaluates the current literature to understand the potential utility of ciprofloxacin‐dexamethasone after airway surgery. Ciprofloxacin‐dexamethasone was found to provide utility with minimal side effects
Cyrus W. Abrahamson, Abbey L. Landini, Jasmine Stewart, Krystal Madkins, James A. Burns, Andrew P. Stein, Jonathan P. Kuriakose   +6 more
wiley   +1 more source

Bepotastine Besilate Ophthalmic Solution 1.5% for Up to 8 Hours Following Dosing Reduces Total Non-Ocular Symptoms, Rhinorrhea, and Tearing in a Multi-Site Clinical Model of Allergic Conjunctivitis [PDF]

, 2009
T.T. Macejko, Edward Meier, M Bergmann, Eugene McLaurin, Fred Kurata, P.J. Gomes, Jon I. Williams, James A. Gow, Timothy R. McNamara   +8 more
openalex   +1 more source

Recent Advancements in the Treatment of Age‐Related Macular Degeneration

Med Research, EarlyView.
ABSTRACT Age‐related macular degeneration (AMD) is a prevalent cause of visual impairment and blindness among the elderly. AMD can be categorized into two subtypes: “wet” and “dry.” Current treatments for wet AMD mainly involve anti‐vascular endothelial growth factor (VEGF) drugs, and there are three U.S.
Shan Liu, Danyang Lv, Junran Sun, Huixun Jia, Fang Zheng, Felipe Pereira, Siddharth Narendran, Zhenyu Dong, Haiyun Liu, Shunxiang Gao, Peirong Huang   +10 more
wiley   +1 more source

Effect of treatment with a topical ophthalmic preparation of 1% nalbuphine solution on corneal sensitivity in clinically normal horses [PDF]

, 2010
Kathryn L. Wotman, Mary E. Lassaline
openalex   +1 more source

A Focus on Natural Autophagy Modulators as Potential Host‐Directed Weapons Against Emerging and Re‐Emerging Viruses

Medicinal Research Reviews, EarlyView.
ABSTRACT Autophagy is a highly conserved intracellular process involved in maintaining homeostasis and in the degradation of damaged organelles and external pathogens. Nature provides complex and varied reservoirs of scaffolds and chemical entities that may have a pivotal role in the search for new therapeutic leads.
Ilaria Cursaro, Sara Rossi, Stefania Butini, Sandra Gemma, Gabriele Carullo, Giuseppe Campiani   +5 more
wiley   +1 more source

Rational Use of Medicine and Its Practice. V; Effects of the Consultation on the Use of Ophthalmic Solutions and an Evaluation of the Consultation Method.

, 1997
RYOKO OHTSUKA, Takao Aoyama, Risa Takayanagi, TOSHIKAZU SEINO, Hideyuki Shimizu, Kouichi Nakamura, Hajime Kotaki, Yasufumi Sawada, Tatsuji Iga   +8 more
openalex   +2 more sources

Nutritional priorities to support GLP‐1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society

Obesity, EarlyView.
Abstract Background Glucagon‐like peptide 1 receptor agonists and combination medications (hereafter collectively referred to as GLP‐1s) are shifting the treatment landscape for obesity. However, real‐world challenges and limited clinician and public knowledge on nutritional and lifestyle interventions can limit GLP‐1 efficacy, equitable results, and ...
Dariush Mozaffarian, Monica Agarwal, Monica Aggarwal, Lydia Alexander, Caroline M. Apovian, Shagun Bindlish, Jonathan Bonnet, W. Scott Butsch, Sandra Christensen, Eugenia Gianos, Mahima Gulati, Alka Gupta, Debbie Horn, Ryan M. Kane, Jasdeep Saluja, Deepa Sannidhi, Fatima Cody Stanford, Emily A. Callahan   +17 more
wiley   +1 more source

The efficacy of bromfenac ophthalmic solution 0.07% dosed once daily in achieving zero-to-trace anterior chamber cell severity following cataract surgery [PDF]

, 2014
Steven Silverstein, Damien F. Goldberg, Mauricio Munoz, Mitchell Jackson   +3 more
openalex   +3 more sources